Cargando…

Transcriptomic analysis identifies CYP27A1 as a diagnostic marker for the prognosis and immunity in lung adenocarcinoma

BACKGROUND: The association between lipid metabolism disorder and carcinogenesis is well-established, but there is limited research on the connection between lipid metabolism-related genes (LRGs) and lung adenocarcinoma (LUAD). The objective of our research was to identify LRGs as the potential biom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Yi, He, Muqun, Huang, Yunjian, Xie, Xianhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565965/ https://www.ncbi.nlm.nih.gov/pubmed/37817081 http://dx.doi.org/10.1186/s12865-023-00572-1

Ejemplares similares

Integrated Analysis of Transcriptome and Prognosis Data Identifies FGF22 as a Prognostic Marker of Lung Adenocarcinoma
por: Liu, Hong-Yan, et al.
Publicado: (2019)

Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape
por: Zhu, Ankang, et al.
Publicado: (2023)

Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma
por: Yang, Weichang, et al.
Publicado: (2023)

Transcriptomic analysis identifies a pan-cancer association of IL27 expression with cancer prognosis and immune microenvironment
por: Liao, Kaili, et al.
Publicado: (2022)

Identifying Common Genes Related to Platelet and Immunity for Lung Adenocarcinoma Prognosis Prediction
por: Zhou, Chengmao, et al.
Publicado: (2020)

Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma
por: Hu, Zhengyang, et al.
Publicado: (2023)

Immune infiltration landscape on prognosis and therapeutic response and relevant epigenetic and transcriptomic mechanisms in lung adenocarcinoma
por: Zhang, Liangming, et al.
Publicado: (2022)

Effect of PTGES3 on the Prognosis and Immune Regulation in Lung Adenocarcinoma
por: Jiang, Wenyan, et al.
Publicado: (2023)

Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers
por: Li, Rui, et al.
Publicado: (2019)

Integrative Multi-Omics Analysis of Identified SKA3 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma
por: Lin, Yuansheng, et al.
Publicado: (2022)

Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma
por: Yun, Sumi, et al.
Publicado: (2016)

A new prognostic model for RHOV, ABCC2, and CYP4B1 to predict the prognosis and association with immune infiltration of lung adenocarcinoma
por: Li, Qiao, et al.
Publicado: (2023)

Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis
por: Li, Dong, et al.
Publicado: (2021)

The screening of immune-related biomarkers for prognosis of lung adenocarcinoma
por: Liu, Zhonghui, et al.
Publicado: (2021)

Rab27b Is a Potential Indicator for Lymph Node Metastasis and Unfavorable Prognosis in Lung Adenocarcinoma
por: Zhang, Louqian, et al.
Publicado: (2018)

Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma
por: Liu, Zi-Tao, et al.
Publicado: (2023)

Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
por: Zhang, Jia-Le, et al.
Publicado: (2023)

Key genes involved with prognosis were identified in lung adenocarcinoma by integrated bioinformatics analysis
por: Song, Hao, et al.
Publicado: (2023)

CYP27A1 mutation in a case of cerebrotendinous xanthomatosis: A case report
por: Li, Zhao-Ran, et al.
Publicado: (2022)

Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis
por: Jiang, Xueping, et al.
Publicado: (2020)

IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis
por: Shi, Xiaoshun, et al.
Publicado: (2020)

TEDC2 correlated with prognosis and immune microenvironment in lung adenocarcinoma
por: Fang, Likui, et al.
Publicado: (2023)

Evaluating the utility of an immune checkpoint-related lncRNA signature for identifying the prognosis and immunotherapy response of lung adenocarcinoma
por: Zhang, Hongpan, et al.
Publicado: (2022)

Identification of immune-associated lncRNAs as a prognostic marker for lung adenocarcinoma
por: He, Chunming, et al.
Publicado: (2021)

Transcriptome analysis of adipocytokines and their-related LncRNAs in lung adenocarcinoma revealing the association with prognosis, immune infiltration, and metabolic characteristics
por: Ren, Jie, et al.
Publicado: (2022)

Comprehensive bioinformatics analysis identifies several potential diagnostic markers and potential roles of cyclin family members in lung adenocarcinoma
por: Gao, Li-Wei, et al.
Publicado: (2018)

DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma
por: Li, Qun, et al.
Publicado: (2017)

Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma
por: Li, Qiaxuan, et al.
Publicado: (2022)

SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas
por: Xiao, Gang, et al.
Publicado: (2023)

The effects of CYP24A1 on clinicopathological features and the prognosis of pancreatic ductal adenocarcinoma
por: Gao, Wei, et al.
Publicado: (2020)

Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2017)

The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation
por: Yin, Yi, et al.
Publicado: (2022)

NCAPD2 is a novel marker for the poor prognosis of lung adenocarcinoma and is associated with immune infiltration and tumor mutational burden
por: Li, Zihao, et al.
Publicado: (2023)

A Connexin-Based Biomarker Model Applicable for Prognosis and Immune Landscape Assessment in Lung Adenocarcinoma
por: Qi, Junqing, et al.
Publicado: (2022)

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
por: Chen, Yingji, et al.
Publicado: (2021)

A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer
por: Wu, Qing, et al.
Publicado: (2023)

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study
por: Li, Xinyan, et al.
Publicado: (2022)

Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma
por: Alghamdi, Rana A., et al.
Publicado: (2023)

A group of long noncoding RNAs identified by data mining can predict the prognosis of lung adenocarcinoma
por: Liao, Meijian, et al.
Publicado: (2018)

Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma
por: Cai, Deng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rqfouje1lsjdjuqbu71c1d3g58